News Daily News Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients Yael L. Maxwell November 04, 2015
News Daily News Despite Drawbacks and Frustration, EHRs Could Have Meaningful Benefit in Acute MI Patients Yael L. Maxwell October 30, 2015
News Daily News A Pesar de la Frustración e Inconvenientes la HCE Podría Beneficiar a Pacientes IAM Yael L. Maxwell October 30, 2015
News Daily News Morphine’s Worrisome Effects on Ticagrelor Affirmed in Pharmacokinetic Study Shelley Wood October 29, 2015
News Daily News Younger Women With STEMI More Likely Than Men to Die In-Hospital L.A. McKeown October 28, 2015
News Daily News Test de troponina I de alta sensibilidad podría eliminar el IM en gran número de pacientes Todd Neale October 13, 2015
News Daily News High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients Todd Neale October 13, 2015
News Daily News Un Estudio Asegura que Muchos Ingresos en la UCI de Pacientes IAM son Innecesarios Todd Neale September 28, 2015
News Daily News Study Hints That Many ICU Admissions for Acute MI Patients May Be Unnecessary Todd Neale September 28, 2015
News Industry News Medicure Announces Filing of sNDA for New AGGRASTAT® Indication September 10, 2015
News Industry News Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI September 09, 2015
News Industry News New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events September 08, 2015
News Industry News US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack September 03, 2015
News Conference News ESC 2015 PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients Yael L. Maxwell September 02, 2015
Presentation ESC 2015 Aldosterone Lethal Effects Blockade in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-Up Presenter: Gilles Montalescot August 30, 2015